Applied and Environmental Microbiology · 2012 · 118 citations · 58 references
Life SciencesImmunologyMicrobiologyImmunoregulationInflammationInnate ImmunityInflammatory SignalingInnate Immune ActivationInnate Immune ModulationInnate Immune RecognitionInnate Immune ResponseToll-like ReceptorsBacterial Immune ModulationBacterial Immune ResponsesImmunomodulatory EffectsInnate Immune CytokinesProinflammatory Cytokine ModulationProinflammatory MediatorsToll-like Receptor SignalingToll-like Receptor-mediated Innate Immune Response
The ability to positively affect host health through the modulation of the immune response is a feature of increasing importance in measuring the probiotic potential of a bacterial strain. However, the identities of the bacterial cell components involved in cross talk with immune cells remain elusive. In this study, we characterized the dairy strain Lactobacillus helveticus MIMLh5 and its surface-layer protein (SlpA) using in vitro and ex vivo analyses. We found that MIMLh5 and SlpA exert anti-inflammatory effects by reducing the activation of NF-κB on the intestinal epithelial Caco-2 cell line. On the contrary, MIMLh5 and SlpA act as stimulators of the innate immune system by triggering the expression of proinflammatory factors tumor necrosis factor alpha and COX-2 in the human macrophage cell line U937 via recognition through Toll-like receptor 2. In the same experiments, SlpA protein did not affect the expression of the anti-inflammatory cytokine interleukin-10. A similar response was observed following stimulation of macrophages isolated from mouse bone marrow or the peritoneal cavity. These results suggest that SlpA plays a major role in mediating bacterial immune-stimulating activity, which could help to induce the host's defenses against and responses toward infections. This study supports the concept that the viability of bacterial cells is not always essential to exert immunomodulatory effects, thus permitting the development of safer therapies for the treatment of specific diseases according to a paraprobiotic intervention.
58
IL-10 inhibits cytokine production by activated macrophages
David Fiorentino, Albert Zlotnik, Tim R. Mosmann et al. · The Journal of Immunology · 1991 · 2.9K citations · Full text
Annalisa D’Andrea, Miguel Aste-Amézaga, Nicholas M. Valiante et al. · The Journal of Experimental Medicine · 1993 · 1.4K citations · Full text